Brendan Eby, MD

Vascular & Endovascular Neurologist, Asst. Professor @WashUNeurology/@BJC_HealthCare| Stroke Director @BJStCharlesCounty| Alum @EmoryNeurosurg| Posts≠advice

[Brendan Eby, MD @NeuroIntervener]

@DineshJillella @EmoryStroke @GradyHealth @MithileshSiddu Destined for great things

[Penumbra Neuro @PenNeuro]

A huge thanks to our esteemed faculty Drs. John Chaloupka, Matt Fiesta, @OrlandoDiazMD, @neurointervener, @brainplumberMD, @robertereplogle, @SunilAShethMD, and @vellimana & to the attendees who helped make the Houston FLIP Navigating Complications Course a resounding success!🧠

[Brendan Eby, MD @NeuroIntervener]

@GregoryZipfel @WashUNeurosurg @WUSTL_ENT @WustlDOVS I would totally push for a couple of virtual endovascular simulators too! 😉

[Brendan Eby, MD @NeuroIntervener]

@olsonplanner @RONALDRIBBONS They decide to pay a delivery driver less per package, and therefore they load up more packages even if it means their route runs behind. The package gets no say if the customer doesn’t pay the premium for priority shipping. Sad result is that patients end up waiting.

[Brendan Eby, MD @NeuroIntervener]

@olsonplanner @RONALDRIBBONS The thing people don’t understand about the American healthcare system is that patients aren’t the client. Those are the insurance companies. Patients (and their treatments) are the product. The pressure is to produce more, even if it compromises the product.

[Brendan Eby, MD @NeuroIntervener]

@DavidAltschulMD Like the BMS to maintain access over the wire, but tricky to size appropriately unless you get good angio of nominal vessel size. Is it drug eluting?

[Brendan Eby, MD @NeuroIntervener]

@AJagolinoCole 👏👏👏

[AshuJadhav @AshuPJadhav]

Optimizing Educational Environments in Stroke and Neurovascular Fields | Stroke https://t.co/FDyTUZU2Hv

[WashU Medicine Neurology @WashUNeurology]

Barnes-Jewish St. Peters Hospital is now a certified Advanced Thrombectomy Capable Stroke Center! This would not have been possible without the tremendous effort of everyone on our team. Thank you and congratulations!

[Sitara Koneru, MD @SitaraKoneru]

🚨Day 3 kicks off with the SVIN/WFITN joint session! @TudorGJovin discusses the results of In Extremis Laste
📍ASPECTS 0-2 vs 3-5- no heterogeneity of treatment effect
📍size of core is NOT a treatment effect modifier
📍don’t exclude patients from treatment based on core size

[Brendan Eby, MD @NeuroIntervener]

@FishingNeurons argues for treating select low NIHSS
✅guidelines say it’s reasonable
✅HEADS-UP maneuver helps select hi risk
✅discussion is disabling vs not, NIHSS not as relevant
@svinsociety @SVINJournal #ENDOLOW @RaulNogueiraMD @SNISinfo

[Brendan Eby, MD @NeuroIntervener]

Debates: @CheesemakerMD argues against MT in LVO with low NIHSS
✅higher rates of lysis pre MY (?40%)
✅occlusions by definition less eloquent
🛑ICAD much more frequent here, up to 1/3rd = more aggressive maneuvers
🛑3-4x risk of sICH

@svinsociety @YoungNIR @rwregen @SNISinfo

[Brendan Eby, MD @NeuroIntervener]

Counterpoint: @hariskamalmd advocates for medical management of asymptomatic carotid stenosis.
- current risk of asymptomatic stenosis can be <1%/yr
- stenosis is dynamic and can even reduce with resolving thrombus or statin use
- need data
@svinsociety #SVIN2023 @CREST2_Study

[Brendan Eby, MD @NeuroIntervener]

Point: @DanielVelaMD discussing how out of date and simplistic NASCET is on modern treatment paradigms for asymptomatic carotid stenosis.
- lessons in stenting mean probable safer treatments
- other high risk features (inteaplaque hemorrhage/ulceration) ignored

[Sitara Koneru, MD @SitaraKoneru]

@EmoryStroke past, present, and future! The best reunion! #SVINAM
.
.
@svinsociety @SVINJournal @Nirav_r_bhatt @ShaerQasem @aboulnourh @DiogoHaussen @Oga_DoctorBlue @zachary_lazzari @fati_k_MD @BouslamaMd @NeuroIntervener @JayDoliaMD @MadhavSambhu

[Giana Dawod, MD @gdawod1]

UPDATED RSVP link -

https://t.co/0iF3ikpMkC

⬆️⬆️⬆️⬆️

[Brendan Eby, MD @NeuroIntervener]

Proud of the #WashUCrew presenting their posters at #SVIN23. Future fellow Luis, our ambitious resident, @mkhasawnehh, and even our superstar Med student Eve Moll! @svinsociety @WashUNeurology @WashUONR @WUSTLmed @YoungNIR @JOsbunMDxCV @vellimana @ranochatterjee

[Brendan Eby, MD @NeuroIntervener]

I’ve been light on Twitter (or “X”) since many of the changes this year but had to hop back on to share the excitement of #SVIN23! @svinsociety @YoungNIR

[AshuJadhav @AshuPJadhav]

Abstracts from the Society of Vascular and Interventional Neurology 2023 Annual Meeting https://t.co/yPVEO2bO14 @StrokeAHA_ASA @SVINJournal @svinsociety #SVIN23

[WashU Medicine Neurology @WashUNeurology]

In today’s #GrandRounds, @UHhospitals' Amrou Sarraj, MD (@amrsarrajMD), discussed levels of evidence for thrombectomy (EVT) and the results of the @SELECT2Trial and how EVT of strokes with a large ischemic core is safe and efficacious.
https://t.co/tJbXWvqI2N

[Brendan Eby, MD @NeuroIntervener]

@WUSTLNeuroICU @WUSTLNeuroICU represent!

[Brendan Eby, MD @NeuroIntervener]

Honored to have @amrsarrajMD guide use through the new era of thrombectomy. Reignites our commitment to #StrikeOutStroke on the eve of #WorldStrokeDay @svinsociety @SNISinfo @WashUNeurology @WashUNeurosurg

[Amrou Sarraj @amrsarrajMD]

It was my pleasure to deliver the key note address @WashUNeurology annual brain attack symposium and grand rounds for the department of Neurology. Thank you @NeuroIntervener for the wonderful hospitality. @JOsbunMDxCV @JinMooLee1